Prednisone Enrolling by Invitation Phase 2 Trials for Castration-Resistant Prostate Cancer (CRPC) / Prostate Cancer Supportive Care

IndicationsStatusPurposePhase
Enrolling by InvitationSupportive Care2
clinicaltrials.gov IdentifierTitleDrugs
NCT03356912CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy